跳至主要内容
临床试验/NCT07581288
NCT07581288尚未招募不适用

Quantitative Hormonal Biomarkers of Uterine Cancer Progression in Patients With Abnormal Uterine Bleeding

University of British Columbia1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年5月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
1

研究概览

简要总结

The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 35 years and older
  • Have experienced AUB

排除标准

  • Currently pregnant or become pregnant during their participation
  • Previous surgeries impairing the menstrual cycle (e.g. hysterectomy, bilateral oophorectomy)
  • Currently or in the previous 3 months on medications that are known to impair or stimulate ovulation (e.g. oral contraceptives, ovulation stimulants, hormone replacement, etc.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aline Talhouk

Assistant Professor

University of British Columbia

研究点 (1)

Loading locations...

相似试验